Advertisement
Screener

Bausch Health Companies Inc. (BHC) Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31)

1.3 / 5 stars · 23/86 Roast Me

Bausch Health Companies Inc. Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31)

Bausch Health Companies Inc. (BHC) reported Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) of 2.3 Y for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.

Discontinued › Notes › Compensation Related Costs

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition · last filed 2012-08-03

  • Bausch Health Companies Inc. employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for the quarter ending 2012-03-31 was 2.50 Y.
Period endEmployee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 3 monthEmployee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 6 month
2012-06-302.30 Y
10-Q · filed 2012-08-03
2012-03-312.50 Y
10-Q · filed 2012-05-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42